glp-1 class action Agonists for Weight Loss: Safe or Risky? GLP-1 for Diabetes vs GLP-1

Most injectable GLP-1 medicationsincluding semaglutide (Wegovy) and tirzepatide (Zepbound)are given once a week

J Cell Physiol 1999

These visits are far more than routine theyre a core reason medical supervision outperforms over-the-counter alternatives

While semaglutide is administered once weekly, tirzepatide offers a slightly broader titration window

Food and Drug Administration (FDA) in 2021, known as Wegovy or semaglutide, aims to help individuals with excess weight lose up to 15% of their body weight

It has been suggested that increased expression of GATA-2 and GATA-3 suppresses adipocyte differentiation through a direct repression of C/EBP- and PPAR [74]